A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia

Case Rep Psychiatry. 2021 Jun 24;2021:5557211. doi: 10.1155/2021/5557211. eCollection 2021.ABSTRACTAripiprazole is an antipsychotic with partial agonist activity at the dopamine D2 receptor which may lead to compulsive behaviors including hypersexuality. The case presented is of a 24-year-old male with schizophrenia who developed hypersexuality symptoms after initiation of aripiprazole. Cessation of the aripiprazole led to a reduction in hypersexual behaviors. Clinicians should be aware of compulsive behaviors including hypersexuality with aripiprazole use and consider discontinuation of aripiprazole treatment in patients suffering from hypersexuality.PMID:34258097 | PMC:PMC8249151 | DOI:10.1155/2021/5557211
Source: Case Reports in Psychiatry - Category: Psychiatry Authors: Source Type: research